David Scheifele
Overview
Explore the profile of David Scheifele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Langley J, Gantt S, Quach C, Bettinger J, Halperin S, Mutch J, et al.
Emerg Infect Dis
. 2020 Feb;
26(3):454-462.
PMID: 32091358
Emergency vaccination programs often are needed to control outbreaks of meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) on college campuses. Such campaigns expend multiple campus and public health...
2.
Scheifele D, Ward B
Paediatr Child Health
. 2018 Jul;
23(4):245-246.
PMID: 30038529
Prophylactic administration of antipyretic/analgesic drugs, started at the time of immunization and repeated 6 and 12 hours later, is sometimes undertaken to reduce postimmunization fever and irritability in infants. Two...
3.
Boikos C, Joseph L, Scheifele D, Lands L, De Serres G, Papenburg J, et al.
Vaccine
. 2017 Aug;
35(37):5019-5026.
PMID: 28774563
Background: Despite the approved use of live-attenuated intranasal influenza vaccine (LAIV) for seasonal immunization of patients with cystic fibrosis (CF), many questions remain unanswered regarding the timing, duration, and types...
4.
Boikos C, Papenburg J, Martineau C, Joseph L, Scheifele D, Chilvers M, et al.
Hum Vaccin Immunother
. 2017 Mar;
13(6):1-7.
PMID: 28273006
Background: The objective of this study was to explore the effects of viral co-detection in individuals recently vaccinated with the live-attenuated intranasal influenza virus vaccine (LAIV) on the detection of...
5.
Boikos C, Joseph L, Martineau C, Papenburg J, Scheifele D, Lands L, et al.
Open Forum Infect Dis
. 2016 Oct;
3(4):ofw187.
PMID: 27747255
We aimed to explore the detection profile of influenza viruses following live-attenuated intranasal influenza vaccination (LAIV) in children aged 2-19 years with and without cystic fibrosis (CF). Before the 2013-2014...
6.
Pinto M, Scheifele D
Paediatr Child Health
. 2014 Nov;
19(8):404.
PMID: 25382994
No abstract available.
7.
Thollot F, Scheifele D, Pankow-Culot H, Cheuvart B, Leyssen M, Ulianov L, et al.
Pediatr Infect Dis J
. 2014 Jul;
33(12):1246-54.
PMID: 25037033
Background: The immunogenicity and safety of the investigational diphtheria, tetanus, acellular pertussis, hepatitis B, poliomyelitis, Haemophilus influenzae type b (Hib) and meningococcal serogroup C (MenC) heptavalent combination vaccine were compared...
8.
Yam K, Gipson E, Klein M, Walmsley S, Haase D, Halperin S, et al.
J Clin Immunol
. 2014 May;
34(6):655-62.
PMID: 24824648
Purpose: More severe influenza disease and poor vaccine immunogenicity is reported in HIV-infected patients. We measured antibody avidity after influenza vaccination in HIV patients to assess vaccine efficacy. Methods: Two...
9.
Omura J, Buxton J, Kaczorowski J, Catterson J, Li J, Derban A, et al.
Can Fam Physician
. 2014 Mar;
60(3):e187-93.
PMID: 24627403
Objective: To explore the experiences of family physicians and pediatricians delivering immunizations, including perceived barriers and supports. Design: Qualitative study using focus groups. Setting: Ten cities throughout British Columbia. Participants:...
10.
Lapphra K, Scheifele D
Paediatr Child Health
. 2012 Oct;
16(8):463.
PMID: 23024581
No abstract available.